Submit your email to push it up the queue
American HomePatient, Inc., a leading provider in the home healthcare industry, is headquartered in the United States and operates across various regions nationwide. Founded in 1983, the company has established itself as a trusted name in delivering quality home medical equipment and services, including respiratory therapy, sleep therapy, and durable medical equipment. With a commitment to patient care, American HomePatient stands out through its comprehensive range of products and personalised services tailored to meet individual needs. The company has achieved significant milestones, including expanding its service offerings and enhancing its operational capabilities, solidifying its position in the competitive healthcare market. Recognised for its dedication to improving patient outcomes, American HomePatient continues to be a vital resource for those seeking reliable home healthcare solutions.
How does American HomePatient, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
American HomePatient, Inc.'s score of 58 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
American HomePatient, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of Linde plc, which influences its climate commitments and emissions reporting. While American HomePatient, Inc. does not have its own documented reduction targets or specific climate pledges, it inherits sustainability initiatives from its parent company, Linde plc. This includes participation in various climate-related frameworks, such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Linde plc. However, specific targets or achievements related to emissions reductions at the subsidiary level have not been disclosed. In the context of the healthcare and home patient services industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. American HomePatient, Inc. is positioned within this evolving landscape, although detailed emissions data and specific commitments remain unspecified at this time.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 16,872,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Scope 2 | 23,518,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Scope 3 | 14,849,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
American HomePatient, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.